Investigation of a New 1-piece Convex Ostomy Product

March 30, 2016 updated by: Coloplast A/S

Investigation of a New 1-piece Convex Ostomy Product in Subjects With Ileostomy and Colostomy

The aim of the investigation was to investigate the performance and safety of a new ostomy product

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Are at least 18 years of age and have full legal capacity.
  • Have had an ileostomy/colostomy for more than 3 months
  • Have used a 1-piece flat ostomy product for the last 1 month
  • Has given written Informed Consent and signed the letter of authority
  • Have an ileostomy or colostomy with a diameter of 33 mm or less
  • Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
  • Are evaluated to be suitable for a soft convex product
  • If having a colostomy: changes their product on average 2 times pr. 24h or more
  • Currently uses a bag of size medi/midi or maxi

Exclusion Criteria:

  • Have a loop ostomy (also called double-barrel or ostomy with two outlets).
  • Are pregnant or breastfeeding
  • Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  • Currently receiving or have within the past month received systemic or local steroid treatment in the peristomal area
  • Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
  • Known hypersensitivity toward any of the test products
  • Participating in other interventional clinical investigations or have previously participated in this investigation
  • Use irrigation during the investigation (flush the intestine with water)
  • Have a fistula in the peristomal area or less than 2 cm from the edge of the baseplate
  • If subject has a colostomy: empties the bag

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: First Coloplast Test

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.

First subjects are allocated to Coloplast Test; Secondly to either

  1. Own product (baseline)
  2. Competitor soft convex
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation. The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e. Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product
Experimental: First Competitor soft convex

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.

First subjects are allocated to Competitor soft convex; Secondly to either

  1. Own product (baseline)
  2. Coloplast Test
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation. The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e. Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product
Experimental: First Own product

The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.

First subjects are allocated to Own product; Secondly to either

  1. Coloplast Test
  2. Competitor soft convex
Newly developed 1-piece convex ostomy product
The subjects Own product is used as baseline performance in this investigation. The products are commercial and available on the market, and are products manufactured by manufactures who produce convex ostomy products i.e. Coloplast, Convatec, Dansac, B.Braun, Hollister and more.
A commercially available soft convex product

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of Leakage
Time Frame: 14 +/- 3 days
The degree of leakage is investigated on a 32-point scale (including 0 for no leakage). O represents no leakage and 32 represents the worst leakage.
14 +/- 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Birte P Jakobsen, MD, Coloplast A/S

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

January 16, 2014

First Submitted That Met QC Criteria

January 21, 2014

First Posted (Estimate)

January 23, 2014

Study Record Updates

Last Update Posted (Estimate)

May 4, 2016

Last Update Submitted That Met QC Criteria

March 30, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CP241

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stoma Ileostomy

Clinical Trials on Coloplast Test

3
Subscribe